Why the study?
Many patients with advanced heart failure and comorbidities are ineligible for advanced therapies, raising the need for palliative strategies focused on symptom relief and quality of life.
Does home use of continuous intravenous milrinone allow dehospitalization and improve quality of life in a patient with advanced heart failure receiving palliative care?
Does home use of continuous intravenous milrinone allow dehospitalization and improve quality of life in a patient with advanced heart failure receiving palliative care?
Home use of continuous intravenous inotropes can be a feasible palliative strategy for dehospitalization and symptom control in advanced heart failure patients within the Brazilian public health system.
Case supports palliative care prioritization in ineligible HF patients; leaves open prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mendes et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: